BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July

Day

• 1
• 2
• 3
• 4
• 7
• 8
• 9
• 10
• 11
• 13
• 14
• 15
• 16
• 17
• 18
• 21
• 22
• 23
• 24
• 25
• 28
• 29
• 30

• Press Releases

  Asieris Pharmaceuticals Releases 2024 Annual Report, with Revenue Exceeding RMB 200M in 1st Year of Commercialization and Innovative Portfolio Accelerating Toward Launch

  April 21, 2025

   · 

  9 min read
• Press Releases

  Dupixent® (dupilumab) Approved in the U.S. as the First New Targeted Therapy in Over a Decade for Chronic Spontaneous Urticaria (CSU)

  April 21, 2025

   · 

  25 min read
• Press Releases

  Regeneron Provides Update on EYLEA HD® (aflibercept) Injection 8 mg Supplemental Biologics License Application

  April 21, 2025

   · 

  11 min read
• Press Releases

  Press Release: Dupixent approved in the US as the first new targeted therapy in over a decade for chronic spontaneous urticaria

  April 21, 2025

   · 

  17 min read
• Press Releases

  Evolus Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - April 18, 2025

  April 21, 2025

   · 

  1 min read
• Press Releases

  Feinstein Institutes Researchers Lead Successful Study Demonstrating Benefit to Patients With Lupus Kidney Disease

  April 21, 2025

   · 

  2 min read
• Press Releases

  New Simplera Sync™ sensor for the MiniMed™ 780G System now FDA approved

  April 21, 2025

   · 

  4 min read
• Press Releases

  IMUNON Announces IMNN-001 Abstract Accepted for Oral Presentation at 2025 ASCO Annual Meeting

  April 21, 2025

   · 

  8 min read
• Press Releases

  Chemomab Therapeutics to Present Nebokitug Clinical Data at Upcoming Scientific Conferences

  April 21, 2025

   · 

  3 min read